Our findings suggest, however, that the temporal meta-ROI (approximating Braak stage I/IV) is suitable for achieving high diagnostic accuracy across tau PET tracers in differentiating AD dementia from CU individuals and non-AD dementia disorders. This evidence concerns the gene MAPT and Alzheimer disease.